Pacific Biosciences of California, Inc.

DB:P09 Stock Report

Market Cap: €463.0m

Pacific Biosciences of California Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:P09 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Mar 24Buy€161,592David MelineIndividual40,000€4.04
04 Mar 24Sell€63,580Christian O. HenryIndividual14,177€4.48
04 Mar 24Sell€23,657Susan KimIndividual5,275€4.48
04 Mar 24Sell€41,197Mark Van OeneIndividual9,186€4.48
04 Mar 24Sell€13,311Michele FarmerIndividual2,968€4.48
20 Feb 24Sell€444,884Christian O. HenryIndividual81,017€5.51
20 Feb 24Sell€127,926Susan KimIndividual23,327€5.51
16 Feb 24Sell€41,819Michele FarmerIndividual7,562€5.53
16 Feb 24Sell€85,707Jeff EidelIndividual15,498€5.53
16 Feb 24Sell€185,594Mark Van OeneIndividual33,560€5.53
09 Jan 24Sell€220,615Mark Van OeneIndividual31,012€7.11
29 Sep 23Sell€153,503Susan KimIndividual19,257€7.97
18 Sep 23Sell€917,715Christian O. HenryIndividual96,844€9.48
17 Aug 23Sell€252,664Jeff EidelIndividual25,936€9.74
16 Aug 23Sell€263,205Mark Van OeneIndividual26,102€10.08
18 May 23Sell€60,391Michele FarmerIndividual5,165€11.69

Insider Trading Volume

Insider Buying: P09 insiders have sold more shares than they have bought in the past 3 months.


Ownership Breakdown

What is the ownership structure of P09?
Owner TypeNumber of SharesOwnership Percentage
Private Companies66,1960.024%
Individual Insiders1,454,1320.528%
Institutions273,882,45899.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9%.


Top Shareholders

Top 25 shareholders own 84.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.2%
ARK Investment Management LLC
33,290,137€56.6m-3.52%0.4%
9.84%
The Vanguard Group, Inc.
26,789,552€45.5m15.1%no data
9.05%
BlackRock, Inc.
24,642,666€41.9m8.67%no data
6.46%
Madrone Advisors, Llc
17,591,915€29.9m7.16%4.55%
4.71%
Nikko Asset Management Co., Ltd.
12,824,385€21.8m-2.85%0.01%
4.17%
T. Rowe Price Group, Inc.
11,353,056€19.3m-0.45%no data
4.15%
BNY Mellon Asset Management
11,311,707€19.2m133%no data
3.98%
Morgan Stanley, Investment Banking and Brokerage Investments
10,829,152€18.4m443%no data
3.56%
Jackson Square Partners, LLC
9,704,766€16.5m40%0.51%
2.69%
Bellevue Asset Management AG
7,317,128€12.4m0.99%0.13%
2.57%
Deep Track Capital, LP
7,000,000€11.9m16.7%0.38%
2.39%
Capital Research and Management Company
6,503,749€11.1m0%no data
2.27%
Farallon Capital Management, L.L.C.
6,191,370€10.5m-39.4%0.07%
2.07%
State Street Global Advisors, Inc.
5,624,329€9.6m4.7%no data
2.03%
Geode Capital Management, LLC
5,516,386€9.4m8.07%no data
2.02%
Point72 Asset Management, L.P.
5,489,580€9.3m104%0.02%
1.83%
Macquarie Investment Management Business Trust
4,971,504€8.5m17%0.01%
1.37%
FMR LLC
3,724,231€6.3m-19.4%no data
1.29%
Madrone Capital Partners
3,500,000€6.0m0%100.0%
1.12%
Dimensional Fund Advisors LP
3,057,262€5.2m-3.13%no data
1.08%
Decheng Capital LLC
2,940,361€5.0m101%0.5%
0.99%
Northern Trust Global Investments
2,697,693€4.6m-4.3%no data
0.97%
Khosla Ventures, LLC
2,632,784€4.5m0%0.27%
0.9%
Lord, Abbett & Co. LLC
2,442,956€4.2m-33.4%0.01%
0.72%
Charles Schwab Investment Management, Inc.
1,966,837€3.3m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.